Original Research
Accepted on 28 Jul 2025
Preexisting Ulcerative Colitis Increases the Risk of Immune-Related Colitis and Predicts Divergent Survival Outcomes in Gastrointestinal Cancer Patients Treated with Immune Checkpoint Inhibitors
in Cancer Immunity and Immunotherapy